US Broker Ratings

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth Challenges in the Medical Device Sector

Integer Holdings Corporation (NYSE: ITGR) stands as a notable player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $4.3 billion, the company operates..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring Growth Potential in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, has been garnering attention for its innovative solutions in diagnostic and therapeutic products. With a market capitalization of..

Universal Health Services, Inc. (UHS) Stock Analysis: Exploring a 14.15% Upside Potential

Universal Health Services, Inc. (NYSE: UHS) presents a compelling opportunity for investors seeking exposure to the healthcare sector. As a prominent player in the medical care facilities industry, UHS operates..

Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Landscape with a Forward P/E of 16.98

Avantor, Inc. (NYSE: AVTR) is a key player in the healthcare sector, focusing on medical instruments and supplies. With a market capitalization of $10.13 billion, Avantor offers a comprehensive range..

Novo Nordisk A/S (NVO) Stock Analysis: A Healthcare Giant with Strong Dividend Yield and Exciting Growth Prospects

Novo Nordisk A/S (NVO), a powerhouse in the healthcare sector, is a Danish company that has carved a niche in the global pharmaceutical landscape, especially in the realm of diabetes..

Teleflex Incorporated (TFX): Stock Analysis Highlights a Promising 10.98% Upside Potential

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, stands as an intriguing prospect for investors seeking exposure to the medical instruments and supplies industry. With a market capitalization..

The Cigna Group (CI) Stock Analysis: Uncovering a Potential 20.85% Upside Amid Robust Growth and Favorable Analyst Ratings

The Cigna Group (CI), a stalwart in the healthcare sector, offers investors a compelling opportunity, particularly when considering its promising upside potential of 20.85%. As a key player in the..

Quest Diagnostics (DGX) Stock Analysis: Insights into a Healthcare Leader with Robust Growth Prospects

Quest Diagnostics Incorporated (NYSE: DGX) stands as a prominent player in the healthcare sector, particularly within the Diagnostics & Research industry. With a market capitalization of $26.17 billion, Quest Diagnostics..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 22.66% Upside Potential

Takeda Pharmaceutical Company L (NYSE: TAK), a stalwart in the healthcare sector, is positioned at a critical juncture with promising upside potential for investors. As a leading player in the..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 24.52% Upside Potential in the Biotech Sector

TG Therapeutics, Inc. (NASDAQ: TGTX) is gaining traction in the biotechnology sector, captivating investors with its cutting-edge therapeutics for B-cell mediated diseases. Based in Morrisville, North Carolina, the company is..

BridgeBio Pharma, Inc. (BBIO) Investor Outlook: Potential 45.77% Upside Amid Robust Pipeline

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands out in the biotechnology sector with a market capitalization of $14.63 billion. Known for its focus on genetic diseases, the company is making headlines..

Natera, Inc. (NTRA) Stock Analysis: A $47.31 Billion Healthcare Innovator with Strong Buy Ratings

Natera, Inc. (NTRA) stands as a formidable player in the healthcare sector, specializing in diagnostics and research. With a market capitalization of $47.31 billion, this Austin-based company has captured the..

Koninklijke Philips N.V. (PHG) Stock Analysis: Uncovering a 24% Potential Upside in the Healthcare Giant

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector with a rich history dating back to 1891, offers intriguing prospects for investors looking to tap into the medical..

Gilead Sciences, Inc. (GILD) Stock Analysis: Evaluating the Prospects with a 4.25% Potential Upside

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, captures investor interest with a robust market capitalization of $187.23 billion. As a leading biopharmaceutical company, Gilead is..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 39% Potential Upside in Healthcare

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, is headquartered in Barcelona, Spain, and has carved out a substantial niche in the drug manufacturing industry. Specializing in plasma-derived..

Pfizer, Inc. (PFE) Stock Analysis: Evaluating the 6.05% Dividend Yield and Its Implications for Investors

Pfizer Inc. (NYSE: PFE), a stalwart in the healthcare sector and a leading player in the global biopharmaceutical industry, continues to capture investor attention with its robust dividend yield and..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Exploring a 36% Upside Potential with Robust Revenue Growth

Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a prominent player in the healthcare sector, stands out for its robust financial health and promising growth trajectory. Specializing in the development and commercialization of..

Globus Medical, Inc. (GMED) Stock Analysis: Healthcare Innovator with a 31.86% Upside Potential

Globus Medical, Inc. (NYSE: GMED), a leading player in the healthcare sector, specializes in developing advanced medical devices designed to address musculoskeletal disorders. With a market capitalization of $10.51 billion,..

Merck & Co., Inc. (MRK) Stock Analysis: Navigating a Healthcare Giant with a $370 Billion Market Cap

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and innovative pharmaceutical advancements. With a market capitalization..

Bruker Corporation (BRKR) Stock Analysis: Insights into Potential Growth with a Market Cap of $8.91 Billion

Bruker Corporation (NASDAQ: BRKR) is a prominent player in the healthcare sector, specifically in the medical devices industry. With a market capitalization of $8.91 billion, this Massachusetts-based company offers a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds